Doxycycline or Ofloxacin for Outpatient Chlamydial Pelvic Inflammatory Disease? A Cost-Benefit and Cost-Effectiveness Analysis
Objective: The current Centers for Disease Control and Prevention (CDC) guidelines include 2 drugs, doxycycline and ofloxacin, for treatment of the chlamydial component of outpatient pelvic inflammatory disease (PID). Although ofloxacin costs about $90 more than doxycycline, doxycycline is frequentl...
Saved in:
Main Authors: | Michael J. Rosenberg (Author), Michael S. Waugh (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1995-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Detection of chlamydial antibodies in women with pelvic inflammatory disease and infertility
by: Ramona Perhar, et al.
Published: (2020) -
Evaluation of Ofloxacin in the Treatment of Laparoscopically Documented Acute Pelvic Inflammatory Disease (Salpingitis)
by: J. F. Peipert, et al.
Published: (1999) -
Prevalence of Gonorrhoeal and/or Chlamydial Infection in Hospitalized Patients with Pelvic Inflammatory Disease
by: Satienpong Jarusintanakorn, et al.
Published: (2008) -
Immunopathogenesis of Chlamydial Pelvic Inflammatory Disease: The Role of Heat-Shock Proteins
by: Jorma Paavonen, et al.
Published: (1994) -
Comparison of Ceftriaxone Plus Weekly Azithromycin or Daily Ofloxacin for Outpatient Treatment of Pelvic Inflammatory Disease: a randomized clinical trial
by: Parisa Moghtadaei, et al.
Published: (2008)